Let's hope for the univariant data to come out at 90% or better. I realize the 80% mark is deemed more than satisfactory by BP but I think blowing past that will be help even more and give AMBS a much needed push upwards as well as some much needed credibility with Lympro.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.